CastleArk Alternatives’s Patterson-UTI PTEN Stock Holding History

CastleArk Alternatives’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$388K	Buy	+33,250	New	+$475K	3.32%	14
2021 Q3	–	Sell	-8,773	Closed	-$87K	–	336
2021 Q2	$87K	Sell	8,773 -8,772	-50%	-$74.2K	1.02%	15
2021 Q1	$125K	Buy	+17,545	New	+$124K	1.25%	17
2019 Q3	–	Sell	-106,640	Closed	-$1.23M	–	38
2019 Q2	$1.23M	Buy	+106,640	New	+$1.37M	0.76%	31
2018 Q1	–	Sell	-104,350	Closed	-$2.4M	–	53
2017 Q4	$2.4M	Buy	+104,350	New	+$2.16M	1.28%	34

Other funds holding PTEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Anomaly Capital Management New York $1.65B AUM 26.47% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CastleArk Alternatives's PTEN Position: Q3 2022 in Review

CastleArk Alternatives opened a new position in Patterson-UTI (PTEN) in Q3 2022: 33,250 shares worth $388K. The stake represents 3.32% of the portfolio and ranks #14 among its holdings. This is a return to the name: CastleArk Alternatives previously reported a position in PTEN as recently as Q2 2021.

CastleArk Alternatives first reported a position in PTEN in Q4 2017 and has held it in 5 quarters since. The position peaked at $2.4M in Q4 2017. 285 funds tracked by Wall St. Rank hold PTEN as of Q3 2022.

CastleArk Alternatives held 33,250 shares of Patterson-UTI worth $388K as of Q3 2022.
Patterson-UTI was a new CastleArk Alternatives position in Q3 2022.
Patterson-UTI made up 3.32% of CastleArk Alternatives's portfolio in Q3 2022, its #14 holding.
CastleArk Alternatives first reported a position in Patterson-UTI in Q4 2017 and has held it in 5 quarters since.
CastleArk Alternatives's Patterson-UTI position peaked at $2.4M in Q4 2017.
285 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2022.

Based on CastleArk Alternatives's 13F filing for Q3 2022, filed 18 Nov 2022.